Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 15,441–15,460 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Glutathione 6%/ascorbic 1%/DMSO 6.25%

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

L-Glutathione inhalation

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Gentamycin 80mg/1000cc 0.9% NS

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Folic acid (pf) 10mg/cc inj

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

5-Fluorouracil 1% ophthal

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

5-Fluorouracil pf in methocel 1% opthal

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

EDTA 3% ophthalmic

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Ethanol 20% ophthal.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Estradiol Cypionate 2mg/cc testosterone cypionoate 50mg

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone phosphate 24mg/ml inj.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone (pf) 0.05 % opth.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Cyano B-12 (Cmpd) 1000mcg/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Cyano B-12 p-f 1000mcg/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Cyanocobalamin 100mcg/ml injection

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Bleomycin Sulfate 1unit/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Bladder Instillation

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

AMP/M-B12/Pyridox/Methionine Inositol

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Acetylcysteine 10% ophthalmic

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine 4% Urethral Gel

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.